Imunon, Inc. Increase (Decrease) in Accrued Liabilities
Imunon, Inc. (IMNN) reported Increase (Decrease) in Accrued Liabilities of $207.22 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2017-11-14
- Imunon, Inc. increase (decrease) in accrued liabilities for the quarter ending 2017-09-30 was -$220.92K, a 182.78% decline year-over-year.
- Imunon, Inc. increase (decrease) in accrued liabilities for the quarter ending 2017-06-30 was $92.08K, a 67.29% decline year-over-year.
- Imunon, Inc. increase (decrease) in accrued liabilities for the quarter ending 2017-03-31 was $336.05K, a 89.57% increase year-over-year.
- Imunon, Inc. increase (decrease) in accrued liabilities for the quarter ending 2016-09-30 was $266.88K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month |
|---|---|---|---|
| 2017-09-30 | -$220.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$128.83K derived: sum of 2 quarters · filed 2017-11-14 | $207.22K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $92.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $428.13K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $336.05K 10-Q · filed 2017-05-12 | ||
| 2016-09-30 | $266.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $548.39K derived: sum of 2 quarters · filed 2017-11-14 | $725.66K 10-Q · filed 2017-11-14 |
| 2016-06-30 | $281.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $458.77K 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $177.27K 10-Q · filed 2017-05-12 | ||
| 2015-09-30 | -$787.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$475.30K derived: sum of 2 quarters · filed 2016-11-10 | -$1.01M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $312.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$220.40K 10-Q · filed 2016-08-15 | |
| 2015-03-31 | -$532.78K 10-Q · filed 2016-05-16 | ||
| 2014-09-30 | -$97.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$430.69K derived: sum of 2 quarters · filed 2015-11-05 | -$932.50K 10-Q · filed 2015-11-05 |
| 2014-06-30 | -$332.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$834.53K 10-Q · filed 2015-08-10 | |
| 2014-03-31 | -$501.81K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |